Higher methadone doses are associated with lower mortality inpatients of opioid dependence in Taiwan

Journal of Psychiatric Research

Volumn 47, Issue 10, 2013, Pages 1530-1534

  Liao, Ding Lieh ^a,b   Chen, Pau Chung ^b,c   Chen, Chia Hsiang ^b,d   Hsieh, Chia Jung ^b   Huang, Yen Fang ^c,e   Shih, Wen Yi ^c,e   Cheng, Joseph J S ^a  

^a Department of Addiction Psychiatry Bali Psychiatric Center   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e CENTER FOR DISEASE CONTROL   (Taiwan)

Author keywords

Addiction; HIV; Methadone; Mortality; Opioid

Indexed keywords

METHADONE; OPIATE;

ADULT; AGE; ARTICLE; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG DEPENDENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; METHADONE TREATMENT; MORTALITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX; TAIWAN; TREATMENT OUTCOME;

ADDICTION; HIV; METHADONE; MORTALITY; OPIOID;

ADULT; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; METHADONE; MIDDLE AGED; MORTALITY; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TAIWAN;

EID: 84881552380     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.07.001     Document Type: Article

References (32)

1. Amato L., Davoli M., Perucci C.A., Ferri M., Faggiano F., Mattick R.P. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment 2005, 28:321-329.
2. Chen C.Y., Wu P.N., Su L.W., Chou Y.J., Lin K.M. Three-year mortality and predictors after release: a longitudinal study of the first-time drug offenders in Taiwan. Addiction 2010, 105:920-927.
3. Chen K.W., Berger C.C., Forde D.P., D'Adamo C., Weintraub E., Gandhi D. Benzodiazepine use and misuse among patients in a methadone program. BMC Psychiatry 2011, 11:90.
4. Chen Y.M., Kuo S.H. HIV-1 in Taiwan. Lancet 2007, 369:623-625.
5. Ciccarone D. Heroin in brown, black and white: structural factors and medical consequences in the US heroin market. International Journal of Drug Policy 2009, 20:277-282.
6. Darke S., Zador D. Fatal heroin 'overdose': a review. Addiction 1996, 91:1765-1772.
7. Davoli M., Bargagli A.M., Perucci C.A., Schifano P., Belleudi V., Hickman M., et al. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction 2007, 102:1954-1959.
8. Degenhardt L., Bucello C., Mathers B., Briegleb C., Ali H., Hickman M., et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction 2011, 106:32-51.
9. Faggiano F., Vigna-Taglianti F., Versino E., Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews 2003, CD002208.
10. Fang C.T., Hsu H.M., Twu S.J., Chen M.Y., Chang Y.Y., Hwang J.S., et al. Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. Journal of Infectious Diseases 2004, 190:879-885.
11. Farrell M., Marsden J. Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction 2008, 103:251-255.
12. Fugelstad A., Stenbacka M., Leifman A., Nylander M., Thiblin I. Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings. Addiction 2007, 102:406-412.
13. Gossop M., Browne N., Stewart D., Marsden J. Alcohol use outcomes and heavy drinking at 4-5 years among a treatment sample of drug misusers. Journal of Substance Abuse Treatment 2003, 25:135-143.
14. Hall W., Zador D. Challenge of reducing drug-related deaths. The Lancet 2000, 356:7-8.
15. Hser Y.I., Hoffman V., Grella C.E., Anglin M.D.A. 33-year follow-up of narcotics addicts. Archives of General Psychiatry 2001, 58:503-508.
16. Huang Y.F., Kuo H.S., Lew-Ting C.Y., Tian F., Yang C.H., Tsai T.I., et al. Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan. Addiction 2011, 106:1437-1445. discussion 1446-7.
17. Hulse G.K., English D.R., Milne E., Holman C.D. The quantification of mortality resulting from the regular use of illicit opiates. Addiction 1999, 94:221-229.
18. Kelly S.M., O'Grady K.E., Mitchell S.G., Brown B.S., Schwartz R.P. Predictors of methadone treatment retention from a multi-site study: a survival analysis. Drug and Alcohol Dependence 2011, 117:170-175.
19. Langendam M.W., van Brussel G.H., Coutinho R.A., van Ameijden E.J. The impact of harm-reduction-based methadone treatment on mortality among heroin users. American Journal of Public Health 2001, 91:774-780.
20. Ling W., Wesson D.R., Charuvastra C., Klett C.J. Acontrolled trial comparing buprenorphine and methadone maintenance in opioid dependence. Archives of General Psychiatry 1996, 53:401-407.
21. Maddux J.F., Prihoda T.J., Vogtsberger K.N. The relationship of methadone dose and other variables to outcomes of methadone maintenance. American Journal on Addictions 1997, 6:246-255.
22. Mattick R.P., Breen C., Kimber J., Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 2009, CD002209.
23. McCowan C., Kidd B., Fahey T. Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study. British Medical Journal 2009, 338:b2225.
24. McLellan A.T., Lewis D.C., O'Brien C.P., Kleber H.D. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association 2000, 284:1689-1695.
25. McLellan A.T., McKay J.R., Forman R., Cacciola J., Kemp J. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction 2005, 100:447-458.
26. Modesto-Lowe V., Brooks D., Petry N. Methadone deaths: risk factors in pain and addicted populations. Journal of General Internal Medicine 2010, 25:305-309.
27. Morgan O., Vicente J., Griffiths P., Hickman M. Trends in overdose deaths from drug misuse in Europe: what do the data tell us?. Addiction 2008, 103:699-700.
28. Preston K.L., Umbricht A., Epstein D.H. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance. Archives of General Psychiatry 2000, 57:395-404.
29. Stenbacka M., Beck O., Leifman A., Romelsjo A., Helander A. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment. Drug and Alcohol Review 2007, 26:55-63.
30. Strain E.C., Bigelow G.E., Liebson I.A., Stitzer M.L. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. Journal of the American Medical Association 1999, 281:1000-1005.
31. Wang S.C., Ho I.K., Tsou H.H., Tian J.N., Hsiao C.F., Chen C.H., et al. CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer. Journal of Clinical Psychopharmacology 2011, 31:463-469.
32. Wittchen H.U., Apelt S.M., Soyka M., Gastpar M., Backmund M., Golz J., et al. Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients. Drug and Alcohol Dependence 2008, 95:245-257.